 | Larimar Therapeutics, Inc. | |||
| NGM : LRMR || Location: United States | ||||
$6.53+0.15 (+2.35%) |
0.51 M | 6.18 - 6.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.192 M |
| March 15, 2024 | 1.630 M |
| Feb. 29, 2024 | 0.507 M |
| Feb. 15, 2024 | 0.618 M |
| Jan. 31, 2024 | 0.340 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.25 | -0.30 | -18.91% |
| 09/30/2023 | -0.23 | -0.21 | 7.85% |
| 06/30/2023 | -0.20 | -0.19 | 4.47% |
| 03/31/2023 | -0.25 | -0.15 | 40.22% |
| 12/31/2022 | -0.28 | -0.21 | 24.46% |
LRMR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 63.800M | Shares Float | 32.398M |
| Short Float | 3.192M | Market Cap | 416.61M |
| Institution ownership | 83.60% | Insider ownership | 1.343% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.84 | Forward EPS | -2.10 |